Evaluation status available after sign-in
About the journal
Frontiers in Cancer Control and Society is an open-access journal published by Frontiers Media S.A. in Switzerland, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 1,950 CHF. Declared review time at DOAJ: 15 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Frontiers Media S.A.
- ISSN
- 2813-835X
- Country
- Switzerland
- Languages
- english
- Access
- Open access
- Declared publication charge
- 1,950 CHF
- Articles in DOAJ
- 28
- Declared review time
- 15 weeks
- Declared peer-review model
- other
- Official website
- https://www.frontiersin.org/journals/cancer-control-and-society
Index listings
- DOAJ · 2025-08-30
- Indexing
- DOAJ
- APC
- 1,950 CHF
- Declared review time (DOAJ)
- 15 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
28
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
15weeks
Works in OpenAlex
43
Last recorded publication year
2026
Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core
h-index
4
i10-index
1
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2026-03-12
- Added to DOAJ
- 2025-08-30
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSS
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 98%
- ORCID iDs in current deposits
- 0%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 9919260013706676
Classification2
Subjects (DOAJ)
Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
LCC codes
RC254-282
Subject areas
- Global Cancer Incidence and Screening
- Global Cancer Incidence and Screening
- Global Cancer Incidence and Screening
- Cancer survivorship and care
- Cancer survivorship and care
- Childhood Cancer Survivors' Quality of Life
- Cancer survivorship and care
- Childhood Cancer Survivors' Quality of Life
Show all subjects (75)
- Childhood Cancer Survivors' Quality of Life
- Patient-Provider Communication in Healthcare
- Women's cancer prevention and management
- BRCA gene mutations in cancer
- BRCA gene mutations in cancer
- Economic and Financial Impacts of Cancer
- Acute Lymphoblastic Leukemia research
- Cancer Risks and Factors
- Cervical Cancer and HPV Research
- Cervical Cancer and HPV Research
- Acute Lymphoblastic Leukemia research
- Cancer Risks and Factors
- Economic and Financial Impacts of Cancer
- Colorectal Cancer Screening and Detection
- Acute Lymphoblastic Leukemia research
- Economic and Financial Impacts of Cancer
- Colorectal Cancer Screening and Detection
- Prostate Cancer Diagnosis and Treatment
- Colorectal Cancer Screening and Detection
- Health Policy Implementation Science
- BRCA gene mutations in cancer
- Cervical Cancer and HPV Research
- Prostate Cancer Treatment and Research
- Palliative Care and End-of-Life Issues
- Advances in Oncology and Radiotherapy
- Advances in Oncology and Radiotherapy
- Palliative Care and End-of-Life Issues
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Diagnosis and Treatment
- Vaccine Coverage and Hesitancy
- Pancreatic and Hepatic Oncology Research
- Health Systems, Economic Evaluations, Quality of Life
- Health disparities and outcomes
- Genetic factors in colorectal cancer
- COVID-19 and healthcare impacts
- Breast Lesions and Carcinomas
- Ethics in Clinical Research
- Head and Neck Cancer Studies
- Pancreatic and Hepatic Oncology Research
- COVID-19 and healthcare impacts
- Breast Lesions and Carcinomas
- Ethics in Clinical Research
- Genetic factors in colorectal cancer
- Ovarian function and disorders
- Physical Activity and Health
- Head and Neck Cancer Studies
- Palliative Care and End-of-Life Issues
- Health Systems, Economic Evaluations, Quality of Life
- Head and Neck Cancer Studies
- Mental Health and Patient Involvement
- Vaccine Coverage and Hesitancy
- Mental Health and Patient Involvement
- Advances in Oncology and Radiotherapy
- Genetic factors in colorectal cancer
- Glioma Diagnosis and Treatment
- Air Quality and Health Impacts
- Glioma Diagnosis and Treatment
- Liver Disease Diagnosis and Treatment
- Meta-analysis and systematic reviews
- Decision-Making and Behavioral Economics
- Reproductive Biology and Fertility
- Lung Cancer Diagnosis and Treatment
- Glioma Diagnosis and Treatment
- Liver Disease Diagnosis and Treatment
- Air Quality and Health Impacts
- Reproductive Biology and Fertility
- Reproductive Biology and Fertility
Keywords (DOAJ)
- cancer
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
Loading community confirmations…
The journal's record in other sources:Web of Science MJLDOAJ